A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Patients with Down Syndrome and Alzheimer's Disease - Pilot Study

Mohammad Haque, Verinder Prasher, Adam Huxley, Geraldine Cassidy

Research output: Contribution to journalArticle

100 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Patients with Down Syndrome and Alzheimer's Disease - Pilot Study'. Together they form a unique fingerprint.

Medicine & Life Sciences